Refining treatment for the men who need it: lessons from the PIVOT trial

by Abern, Michael R., Tsivian, Matvey, Polascik, Thomas J.
Published 2013

The use of 1,25α dihydroxyvitamin D3 as a cryosensitizing agent in a murine prostate cancer model

by Santucci, Kimberly L., Snyder, Kristi K., Baust, John. M., Van Buskirk, Robert G., Mouraviev, Vladimir, Polascik, Thomas J., Gage, Andrew A., Baust, John G.
Published 2011

Prostatic Alpha-Linolenic Acid (ALA) Is Positively Associated with Aggressive Prostate Cancer: A Relationship Which May Depend on Genetic Variation in ALA Metabolism

by Azrad, Maria, Zhang, Kui, Vollmer, Robin T., Madden, John, Polascik, Thomas J., Snyder, Denise C., Ruffin, Mack T., Moul, Judd W., Brenner, Dean, Hardy, Robert W., Demark-Wahnefried, Wendy
Published 2012

IDENTIFYING CLINICALLY SIGNIFICANT PROSTATE CANCERS USING 3-D IN VIVO ACOUSTIC RADIATION FORCE IMPULSE IMAGING WITH WHOLE-MOUNT HISTOLOGY VALIDATION

by Palmeri, Mark L., Glass, Tyler J., Miller, Zachary A., Rosenzweig, Stephen J., Buck, Andrew, Polascik, Thomas J., Gupta, Rajan T., Brown, Alison F., Madden, John, Nightingale, Kathryn R.
Published 2016

The Role of Focal Therapy in the Management of Localised Prostate Cancer: A Systematic Review

by Valerio, Massimo, Ahmed, Hashim U., Emberton, Mark, Lawrentschuk, Nathan, Lazzeri, Massimo, Montironi, Rodolfo, Nguyen, Paul L., Trachtenberg, John, Polascik, Thomas J.
Published 2014

Focal Therapy: Patients, Interventions, and Outcomes—A Report from a Consensus Meeting

by Donaldson, Ian A., Alonzi, Roberto, Barratt, Dean, Barret, Eric, Berge, Viktor, Bott, Simon, Bottomley, David, Eggener, Scott, Ehdaie, Behfar, Emberton, Mark, Hindley, Richard, Leslie, Tom, Miners, Alec, McCartan, Neil, Moore, Caroline M., Pinto, Peter, Polascik, Thomas J., Simmons, Lucy, van der Meulen, Jan, Villers, Arnauld, Willis, Sarah, Ahmed, Hashim U.
Published 2015